ABOS
NASDAQ · Biotechnology
Acumen Pharmaceuticals Inc
$0.21
0.00 (-1.83%)
Performance
1D
—
1W
-9.70%
1M
-87.91%
3M
-92.19%
6M
-90.74%
1Y
-90.74%
YTD
-90.74%
Open$0.22
Previous Close$0.22
Day High$0.23
Day Low$0.19
52W High$3.60
52W Low$0.19
Volume—
Avg Volume13.15M
Market Cap15.48M
P/E Ratio—
EPS$-1.55
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$1.90
Below
RSI (14)
17.2
Oversold
Analyst Ratings
Strong Sell
11 analysts
Price Target
+10,283.2% upside
Current
$0.21
$0.21
Target
$22.22
$22.22
$18.81
$22.22 avg
$35.10
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 32.13M | 32.40M | 26.28M |
| Net Income | 3.79M | 3.97M | 2.79M |
| Profit Margin | 11.8% | 12.2% | 10.6% |
| EBITDA | 5.50M | 6.39M | 4.32M |
| Free Cash Flow | 1.86M | 2.43M | 2.61M |
| Rev Growth | +20.9% | +8.5% | +2.1% |
| Debt/Equity | 0.36 | 0.35 | 0.35 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |